• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

6 'Work-At-Home' and Telemedicine Stocks You Should Know About

These names should do well as long as the coronavirus is a threat, and still continue to grow once it is past.
By MONEYSHOW.COM
Mar 18, 2020 Updated Apr 10, 2020 | 02:00 PM EDT
Stocks quotes in this article: WORK, ZM, TDOC, ANTM, UNH, HUM

The "work at home" and tele-medicine themes are both seeing a great deal of attention due to the coronavirus. These stocks should do well as long as coronavirus is a threat, and should still continue to grow once it is a distant memory, notes Eddy Elfenbein, a contributor to MoneyShow.com and the editor of Growth Stock Advisor.

Slack Technologies  (WORK) describes their software as a "collaboration hub that brings the right people, information, and tools together to get work done." The software lets teams work together on projects, whether team members are located in the next cubicle, or halfway around the globe.

And that is why the stock has done so well, as coronavirus fears have taken root. With Slack, no one needs to come into an office, and business continues as usual.

Now, it's not a replacement for physically manufacturing products, but almost any white-collar job can be performed at least to some degree, if not completely, using the Slack platform.

Slack was one of the underperforming IPOs of 2019. But after being cut in half, it appears to have found a bottom and has turned higher with the news of coronavirus.

More and more companies small and large are finding they can convey information, and market to their potential customers via webinars. And the number one way to do this is via Zoom Video Communications  (ZM) .

Zoom provides a webinar platform that is easy to use, and that can accommodate up to 10,000 viewers at one time. This makes the two-way platform great for meetings, presentations, or quick check-ins with telecommuters. A combination of Slack, for collaborative project work, and Zoom, for face-to-face communication, provides all a stay-at-home worker could need.

Like Slack, Zoom is a young company with plenty of runway for growth.

Teladoc Health (TDOC) is a virtual health care provider. The company links consumers with medical professionals via phone, tablet, or computer. This model was already taking off before coronavirus and has gotten a major boost from the virus outbreak.

One of the last things I want to do when I'm sick is go to the doctor with all the other sick people. The Teladoc model is completely logical and should continue to do well even when a vaccine for coronavirus is found. The model is perfect for millennials, now one of the largest segments of the U.S. population, who are completely comfortable doing everything electronically.

The company reported revenue of $156 million in the fourth quarter of 2019, an increase of 27% year over year. Total visits using the Teladoc platform increased by 44% to 1.2 million. I believe this is just scratching the surface of where this service can go. While the stock is not cheap, it should quickly grow into its valuation, especially if the coronavirus outbreak worsens.

Meanwhile, many of the large insurers have moved into the telemedicine arena. While not a large part of their business yet, I believe it will grow much larger, with coronavirus acting as an accelerant to this new business line.

Here are three large companies that are already providing a telemedicine option.

Anthem (ANTM) delivers doctor visits to your phone through its telemedicine platform called LiveHealth Online. Anthem has set up a clean, easy to use website that provides visitors with short videos on how LiveHealth works, and what the process is like to "see" a doctor.

This is an important piece of the puzzle for customers who may be elderly and not be as familiar with technology as younger users.

The process is very much like seeing a doctor in person. The patient tells the doctor what their symptoms are, the doctor conducts an exam via the telephone or tablet, and then a treatment plan is devised. This can include a prescription if that is what is needed.

Anthem, like other stocks, has been volatile the past month but has held up well overall. The company recently traded at a PE of 15.5 and yields 1.6%. Full year 2019 revenue grew 12.9% year over year to $103.1 billion.

UnitedHealth Group (UNH) offers its Virtual Visits to anyone needing to see a doctor with a wide range of symptoms and afflictions, from seasonal flu to fever to pinkeye.

And, the platform offers the opportunity to speak directly with a doctor in 20 minutes or less, from the time you initiate the visit. I don't know about you, but I don't remember the last time I spent less than a half-hour in any waiting room for a doctor's visit.

Like the other companies here, if your insurance plan covers a doctor visit, it also covers a telemedicine visit. Even mental health visits, if covered under your plan, are also available using the Virtual Visit.

UnitedHealth had revenue of $242 billion last year, which was a 7% year over year increase. Fourth-quarter earnings came in at $3.90 per share, representing 19% year-over-year growth for the company.

A few years ago, Humana  (HUM) accelerated its technology push across a broad range of areas. This includes building a customer's health history into a cradle to grave system, and a focus on areas such as telemedicine.

Humana emphasizes in its virtual visit that the doctor you are visiting on their telemedicine platform is board certified and that the connection for your virtual visit is secure.

This is an important selling point to an elderly clientele that wants assurances they are seeing the same caliber of doctor via a virtual visit. And, to both the elderly and younger market that wants a secure way to provide their confidential medical information.

Humana earned $3.84 per share in fourth-quarter 2019, a 48% year over year increase. The company is expected to grow its Medicare Advantage membership base by between 7.5% and 9.2% in 2020, which should provide a nice boost to 2020 earnings.

Each of these three companies has held up well in this market, have outstanding growth overall, and should continue to benefit from telemedicine offering long after coronavirus is a distant memory.

(This story was originally published March 18 on Real Money.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Fundamental Analysis | Investing | Markets | Stocks | Trading

More from Stocks

Don't Let the Rally Fool You

Helene Meisler
Apr 22, 2021 6:00 AM EDT

We saw a bounce in speculative stocks, but we need more than that to get the indicators to change.

The Pressure Finally Lifts, but Bumpy Ride Likely Awaits

James "Rev Shark" DePorre
Apr 21, 2021 4:37 PM EDT

The sour mood suddenly lifted, and stocks enjoyed some very robust action, but that's no reason to let your guard down.

Alphabet Shares Should Continue to Live Higher

Bruce Kamich
Apr 21, 2021 3:11 PM EDT

Let's examine the charts of the 'G' in FAANG.

Will Clover Health Investments Turn Around?

Bruce Kamich
Apr 21, 2021 2:30 PM EDT

Let's take a look at 2 charts.

Novavax Is Poised for Renewal After Its Correction

Bruce Kamich
Apr 21, 2021 1:54 PM EDT

Here's our updated analysis and trading strategy.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:17 PM EDT REAL MONEY

    Wednesday on Real Money Pro

    Get-rich quick schemes offer little more than pipe...
  • 11:09 AM EDT GARY BERMAN

    S&P Futures

    FIBOCALL: The S&P futures was off 1.5 %... ...
  • 07:47 AM EDT CHRIS VERSACE

    Positive News for a Cannabis Play

    Good news for this name in the Stocks Under $10 po...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login